Different Impact of Diabetes Mellitus on In-hospital and 1-Year Mortality in Patients with Acute Myocardial Infarction Who Underwent Successful Percutaneous Coronary Intervention: Results from the Korean Acute Myocardial Infarction Registry
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background/Aims: The aim of this study was to evaluate the impact of diabetes mellitus (DM) on in-hospital and 1-year mortality in patients who suffered acute myocardial infarction (AMI) and underwent successful percutaneous coronary intervention (PCI). Methods: Among 5,074 consecutive patients from the Korea AMI Registry with successful revascularization between November 2005 and June 2007, 1,412 patients had a history of DM. Results: The DM group had a higher mean age prevalence of history of hypertension, dyslipidemia, ischemic heart disease, high Killip class, and diagnoses as non-ST elevation MI than the non-DM group. Left ventricular ejection fraction (LVEF) and creatinine clearance were lower in the DM group, which also had a significantly higher incidence of in-hospital and 1-year mortality of hospital survivors (4.6% vs. 2.8%, p = 0.002; 5.0% vs. 2.5%, p < 0.001). A multivariate analysis revealed that independent predictors of in-hospital mortality were Killip class IV or III at admission, use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers, LVEF, creatinine clearance, and a diagnosis of ST-elevated MI but not DM. However, a multivariate Cox regression analysis showed that DM was an independent predictor of 1-year mortality (hazard ratio, 1.504; 95% confidence interval, 1.032 to 2.191). Conclusions: DM has a higher association with 1-year mortality than in-hospital mortality in patients with AMI who underwent successful PCI. Therefore, even when patients with AMI and DM undergo successful PCI, they may require further intensive treatment and continuous attention.
Abstract
Background/Aims: The aim of this study was to evaluate the impact of diabetes mellitus (DM) on in-hospital and 1-year mortality in patients who suffered acute myocardial infarction (AMI) and underwent successful percutaneous coronary intervention (PCI). Methods: Among 5,074 consecutive patients from the Korea AMI Registry with successful revascularization between November 2005 and June 2007, 1,412 patients had a history of DM. Results: The DM group had a higher mean age prevalence of history of hypertension, dyslipidemia, ischemic heart disease, high Killip class, and diagnoses as non-ST elevation MI than the non-DM group. Left ventricular ejection fraction (LVEF) and creatinine clearance were lower in the DM group, which also had a significantly higher incidence of in-hospital and 1-year mortality of hospital survivors (4.6% vs. 2.8%, p = 0.002; 5.0% vs. 2.5%, p < 0.001). A multivariate analysis revealed that independent predictors of in-hospital mortality were Killip class IV or III at admission, use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers, LVEF, creatinine clearance, and a diagnosis of ST-elevated MI but not DM. However, a multivariate Cox regression analysis showed that DM was an independent predictor of 1-year mortality (hazard ratio, 1.504; 95% confidence interval, 1.032 to 2.191). Conclusions: DM has a higher association with 1-year mortality than in-hospital mortality in patients with AMI who underwent successful PCI. Therefore, even when patients with AMI and DM undergo successful PCI, they may require further intensive treatment and continuous attention.
참고문헌 (28)
- Kannel WB, "Diabetes and cardiovascular disease: the Framingham study", JAMA, 241, pp.2035~2038 (1979)
- Stein B, "Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty", Circulation, 91, pp.979~989 (1995)
- Garg P, "Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry", Circulation, 118, pp.2277~2285 (2008)
- Haffner SM, "Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction", N Engl J Med, 339, pp.229~234 (1998)
- Sprafka JM, "Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival: the Minnesota Heart Survey", Diabetes Care, 14, pp.537~543 (1991)
- French JK, "Clinical implications of the new definition of myocardial infarction", Heart, 90, pp.99~106 (2004)
- Mak KH, "Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction: GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries", J Am Coll Cardiol, 30, pp.171~179 (1997)
- Koek HL, "Shortand long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus", Eur J Epidemiol, 22, pp.883~888 (2007)
- Hirakawa Y, "Influence of diabetes mellitus on in-hospital mortality in patients with acute myocardial infarction in Japan: a report from TAMIS-II", Diabetes Res Clin Pract, 75, pp.59~64 (2007)
- Kvan E, "High mortality in diabetic patients with acute myocardial infarction: cardiovascular co-morbidities contribute most to the high risk", Int J Cardiol, 121, pp.184~188 (2007)
- Norhammar A, "Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission", Heart, 93, pp.1577~1583 (2007)
- Hasin T, "Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus", Am J Cardiol, 103, pp.772~778 (2009)
- Hasdai D, "Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes", J Am Coll Cardiol, 35, pp.1502~1512 (2000)
- Woodfield SL, "Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience", J Am Coll Cardiol, 28, pp.1661~1669 (1996)
- Aronson D, "Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction", Ann Intern Med, 126, pp.296~306 (1997)
- Moreno PR, "New aspects in the pathogenesis of diabetic atherothrombosis", J Am Coll Cardiol, 44, pp.2293~2300 (2004)
- Kornowski R, "Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular ultrasound study", Circulation, 95, pp.1366~1369 (1997)
- Creager MA, "Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I", Circulation, 108, pp.1527~1532 (2003)
- Elezi S, "Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement", J Am Coll Cardiol, 32, pp.1866~1873 (1998)
- Dibra A, "Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients", N Engl J Med, 353, pp.663~670 (2005)
- Mehilli J, "Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel", Circulation, 110, pp.3627~3635 (2004)
- Kalarus Z, "Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention", Am Heart J, 153, pp.304~312 (2007)
- West NE, "Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients", Circulation, 109, pp.867~873 (2004)
- Radke PW, "Relation of fasting insulin plasma levels to restenosis after elective coronary stent implantation in patients without diabetes mellitus", Am J Cardiol, 93, pp.639~641 (2004)
- Takagi T, "Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantation: intravascular ultrasound studies", J Diabetes Complications, 16, pp.50~55 (2002)
- Piatti P, "Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting", Circulation, 108, pp.2074~2081 (2003)
- Takara A, "Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization", Cardiovasc Diabetol, 9, pp.1~ (2010)
- Hong YJ, "The role of C-reactive protein on the long-term clinical outcome after primary or rescue percutaneous coronary intervention", Korean J Intern Med, 18, pp.29~34 (2003)